Cargando…

Interim result of phase II, prospective, single-arm trial of long-course chemoradiotherapy combined with concurrent tislelizumab in locally advanced rectal cancer

BACKGROUND: Neoadjuvant chemoradiotherapy is the standard treatment for locally advanced rectal cancer, with modest benefits on tumor regression and survival. Since chemoradiotherapy combined with immune checkpoint inhibitors has been reported to have synergic effects. This study aims to explore the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jiale, Zhang, Xiao, Yang, Zhengyang, Zhang, Jie, Bai, Zhigang, Deng, Wei, Chen, Guangyong, Xu, Rui, Wei, Qi, Liu, Yishan, Han, Jiagang, Li, Ang, Liu, Gang, Sun, Yi, Kong, Dalu, Yao, Hongwei, Zhang, Zhongtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933500/
https://www.ncbi.nlm.nih.gov/pubmed/36816939
http://dx.doi.org/10.3389/fonc.2023.1057947